MELI, Maria
MELI, Maria
Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”
4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors
2014-01-01 Baruchello, R; Simoni, D; Marchetti, P; Rondanin, R; Mangiola, S; Costantini, C; Meli, M; Giannini, G; Vesci, L; Carollo, V; Brunetti, T; Battistuzzi, G; Tolomeo, M; Cabri W
Antitumor effects of novel co-drugs linking histone deacetylase and ribonucleotide reductase inhibitors in hematological tumors
2011-01-01 Ferro, A; Cappellacci, L; Mingrino, A; Petrelli, R; Tolomeo, M; Vita, P; D'Alessandro, N; Dusonchet, L; Franchetti, P; Grifantini, M; Meli, M
Antitumor profile of new phenothiazine derivatives.
2007-01-01 A BISI; MELI M; S GOBBI; A RAMPA; M TOLOMEO; L DUSONCHET
Cytotoxic and apoptotic effects of thiophenfurin in combination with retinoids in human promyelocitic leucemia HL60 cells
2005-01-01 M MELI; M TOLOMEO; M GRIFANTINI; PFRANCHETTI; L CAPPELLACCI; D SIMONI; FP INVIDIATA; DUSONCHET L
Effects of Pimozide Derivatives on pSTAT5 in K562 Cells
2017-01-01 Rondanin, Riccardo*; Simoni, Daniele; Maccesi, Martina; Romagnoli, Romeo; Grimaudo, Stefania; Pipitone, Rosaria Maria; Meli, Maria; Cascio, Antonio; Tolomeo, Manlio
Epigenetic agents as an adjunct to active chemotherapy in hematological tumor cell lines
2012-01-01 Ferro, A; Tolomeo, M; Cappellacci, L; Dusonchet, L; Petrelli, R; Franchetti, P; D'Alessandro, N; Grifantini, M; Meli, M
Expression of IAPs (Inhibitory of Apoptosis Proteins) and of their alternative splice variants in hepatocellular carcinoma tissues and cells
2004-01-01 NOTARBARTOLO DI VILLAROSA, M; CERVELLO, M; GIANNITRAPANI, L; MELI, M; POMA, P; DUSONCHET, L; MONTALTO, G; D'ALESSANDRO, N
Expression of the IAPs in multidrug resistant tumor cells
2004-01-01 NOTARBARTOLO M; CERVELLO M; POMA P; DUSONCHET L; MELI M; D'ALESSANDRO N
Farmaci antimicrotubulari
2020-01-01 Maria Meli; Liboria Travagliato; Natale D'Alessandro
Farmaci antimicrotubulari
2017-01-01 Meli Maria, Liboria Travagliato, D'Alessandro Natale
Farmaci antimicrotubulari.
2005-01-01 MELI M; N DALESSANDRO
FARMACI INIBITORI DELLE TOPOISOMERASI
2020-01-01 M. Meli; L. Travagliato; N. D'Alessandro
Farmaci inibitori delle topoisomerasi
2017-01-01 Meli Maria, Liboria Travagliato, Natale D'Alessandro
Farmacovigilanza attiva sul ruolo dei farmaci antiangiogenetici nell’osteonecrosi dei mascellari
2013-01-01 Morreale, I; Meli, M; Di Fede, O; Campisi, G; D'Alessandro, N
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: Synthesis and biological evaluation of valproic esters of 3’-C-methyladenosine
2014-01-01 Petrelli,R; Meli,M; Vita,P; Torquati,I; Ferro,A; Vodnala,M; D’Alessandro,N; Tolomeo,M; Del Bello,F; Kusumanchi,P; Franchetti,P; Grifantini,M; Jayaram,HN; Hofer,A; Cappellacci,L
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells
2008-01-01 Tolomeo, M; Grimaudo, S; Di Cristina, A; Pipitone, RM; Dusonchet, L; Meli, M; Crosta, L; Gebbia, N; Invidiata, F; Titone Lanza di Scalea, L; Simoni, D
Hepatotoxicity caused by mebendazole in a patient with Gilbert's syndrome
2019-01-01 Manlio Tolomeo; Claudia Colomba; Maria Meli; Antonio Cascio
Heterocyclic and Phenyl Double-Bond-Locked Combretastatin Analogues Possessing Potent Apoptosis-inducing activity in HL60 and in MDR Cell lines
2005-01-01 SIMONI D; GRISOLIA G; GIANNINI G; ROBERTI M; RONDANIN R; PICCAGLI L; BARUCHELLO R; ROSSI M; ROMAGNOLI R; INVIDIATA FP; GRIMAUDO S; JUNG MK; HAMEL E; GEBBIA N; CROSTA L; ABBADESSA V; DI CRISTINA A; DUSONCHET L; MELI M; TOLOMEO M
Histone deacetylase (HDAC) inhibition modulates intracellular deoxynucleotides (dNTP) pools and potentiates the antitumor effects of the ribonucleotide reductase (RR) inhibitor 3’-Methyl-adenosine (3’-Me-Ado) in promyelocitic leukaemia cell lines.
2009-01-01 Meli, M; Tolomeo, M; Grifantini, M; Mai, A; Cappellacci, L; Franchetti, P; Saiko, P; Dusonchet, L
Histone deacetylase (HDAC) inhibitors potentiate the antiproliferative and apoptotic effects induced by the novel ribonucleotide reductase (RR) inhibitor 3'-metil-adenosine (3'-Me-Ado) in promyelocitic leukemia cell lines
2008-01-01 MELI M; TOLOMEO M; GRIFANTINI M; MAI A; CAPPELLACCI L; FRANCHETTI P; ROTILI D; VALENTE S; DUSONCHET L
| Data di pubblicazione | Titolo | Autori | Tipologia | Autore(i) | File |
|---|---|---|---|---|---|
| 1-gen-2014 | 4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors | MELI, Maria + | 01 - Contributo in rivista::1.01 Articolo in rivista | Baruchello, R; Simoni, D; Marchetti, P; Rondanin, R; Mangiola, S; Costantini, C; Meli, M; Giannini, G; Vesci, L; Carollo, V; Brunetti, T; Battistuzzi, G; Tolomeo, M; Cabri W | |
| 1-gen-2011 | Antitumor effects of novel co-drugs linking histone deacetylase and ribonucleotide reductase inhibitors in hematological tumors | FERRO, AriannaD'ALESSANDRO, NataleDUSONCHET, LuisaMELI, Maria + | 10 - Proceedings::Proceedings | Ferro, A; Cappellacci, L; Mingrino, A; Petrelli, R; Tolomeo, M; Vita, P; D'Alessandro, N; Dusonchet, L; Franchetti, P; Grifantini, M; Meli, M | |
| 1-gen-2007 | Antitumor profile of new phenothiazine derivatives. | MELI, MariaDUSONCHET, Luisa + | 10 - Proceedings::Proceedings | A BISI; MELI M; S GOBBI; A RAMPA; M TOLOMEO; L DUSONCHET | |
| 1-gen-2005 | Cytotoxic and apoptotic effects of thiophenfurin in combination with retinoids in human promyelocitic leucemia HL60 cells | MELI, MariaINVIDIATA, FrancescoDUSONCHET, Luisa + | 10 - Proceedings::Proceedings | M MELI; M TOLOMEO; M GRIFANTINI; PFRANCHETTI; L CAPPELLACCI; D SIMONI; FP INVIDIATA; DUSONCHET L | |
| 1-gen-2017 | Effects of Pimozide Derivatives on pSTAT5 in K562 Cells | Simoni, DanieleGrimaudo, StefaniaPipitone, Rosaria MariaMeli, MariaCascio, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Rondanin, Riccardo*; Simoni, Daniele; Maccesi, Martina; Romagnoli, Romeo; Grimaudo, Stefania; Pipitone, Rosaria Maria; Meli, Maria; Cascio, Antonio; Tolomeo, Manlio | |
| 1-gen-2012 | Epigenetic agents as an adjunct to active chemotherapy in hematological tumor cell lines | FERRO, AriannaDUSONCHET, LuisaD'ALESSANDRO, NataleMELI, Maria + | 10 - Proceedings::Proceedings | Ferro, A; Tolomeo, M; Cappellacci, L; Dusonchet, L; Petrelli, R; Franchetti, P; D'Alessandro, N; Grifantini, M; Meli, M | |
| 1-gen-2004 | Expression of IAPs (Inhibitory of Apoptosis Proteins) and of their alternative splice variants in hepatocellular carcinoma tissues and cells | NOTARBARTOLO DI VILLAROSA, MonicaGIANNITRAPANI, LydiaMELI, MariaPOMA, PaolaDUSONCHET, LuisaMONTALTO, GiuseppeD'ALESSANDRO, Natale + | 01 - Contributo in rivista::1.01 Articolo in rivista | NOTARBARTOLO DI VILLAROSA, M; CERVELLO, M; GIANNITRAPANI, L; MELI, M; POMA, P; DUSONCHET, L; MONTALTO, G; D'ALESSANDRO, N | |
| 1-gen-2004 | Expression of the IAPs in multidrug resistant tumor cells | NOTARBARTOLO DI VILLAROSA, MonicaPOMA, PaolaDUSONCHET, LuisaMELI, MariaD'ALESSANDRO, Natale + | 01 - Contributo in rivista::1.01 Articolo in rivista | NOTARBARTOLO M; CERVELLO M; POMA P; DUSONCHET L; MELI M; D'ALESSANDRO N | |
| 1-gen-2020 | Farmaci antimicrotubulari | Maria MeliNatale D'Alessandro + | 02 - Contributo in volume::2.01 Capitolo o Saggio | Maria Meli; Liboria Travagliato; Natale D'Alessandro | |
| 1-gen-2017 | Farmaci antimicrotubulari | Meli MariaLiboria TravagliatoD'Alessandro Natale | 02 - Contributo in volume::2.01 Capitolo o Saggio | Meli Maria, Liboria Travagliato, D'Alessandro Natale | |
| 1-gen-2005 | Farmaci antimicrotubulari. | MELI, MariaD'ALESSANDRO, Natale | 03 - Monografia::3.1 Monografia | MELI M; N DALESSANDRO | |
| 1-gen-2020 | FARMACI INIBITORI DELLE TOPOISOMERASI | M. MeliN. D'Alessandro + | 02 - Contributo in volume::2.01 Capitolo o Saggio | M. Meli; L. Travagliato; N. D'Alessandro | |
| 1-gen-2017 | Farmaci inibitori delle topoisomerasi | Liboria TravagliatoMELI, MariaD'ALESSANDRO, Natale | 02 - Contributo in volume::2.01 Capitolo o Saggio | Meli Maria, Liboria Travagliato, Natale D'Alessandro | |
| 1-gen-2013 | Farmacovigilanza attiva sul ruolo dei farmaci antiangiogenetici nell’osteonecrosi dei mascellari | MELI, MariaDI FEDE, OlgaCAMPISI, GiuseppinaD'ALESSANDRO, Natale + | 10 - Proceedings::Proceedings | Morreale, I; Meli, M; Di Fede, O; Campisi, G; D'Alessandro, N | |
| 1-gen-2014 | From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: Synthesis and biological evaluation of valproic esters of 3’-C-methyladenosine | MELI, MariaFERRO, AriannaD'ALESSANDRO, Natale + | 01 - Contributo in rivista::1.01 Articolo in rivista | Petrelli,R; Meli,M; Vita,P; Torquati,I; Ferro,A; Vodnala,M; D’Alessandro,N; Tolomeo,M; Del Bello,F; Kusumanchi,P; Franchetti,P; Grifantini,M; Jayaram,HN; Hofer,A; Cappellacci,L | |
| 1-gen-2008 | Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells | GRIMAUDO, StefaniaDI CRISTINA, AntoniettaPIPITONE, Rosaria MariaDUSONCHET, LuisaMELI, MariaGEBBIA, Nicolo'INVIDIATA, FrancescoTITONE LANZA DI SCALEA, Lucina + | 01 - Contributo in rivista::1.01 Articolo in rivista | Tolomeo, M; Grimaudo, S; Di Cristina, A; Pipitone, RM; Dusonchet, L; Meli, M; Crosta, L; Gebbia, N; Invidiata, F; Titone Lanza di Scalea, L; Simoni, D | |
| 1-gen-2019 | Hepatotoxicity caused by mebendazole in a patient with Gilbert's syndrome | Claudia ColombaMaria MeliAntonio Cascio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Manlio Tolomeo; Claudia Colomba; Maria Meli; Antonio Cascio | |
| 1-gen-2005 | Heterocyclic and Phenyl Double-Bond-Locked Combretastatin Analogues Possessing Potent Apoptosis-inducing activity in HL60 and in MDR Cell lines | Rossi, MatteoINVIDIATA, FrancescoGRIMAUDO, StefaniaGEBBIA, Nicolo'CROSTA, LuciaABBADESSA, VincenzoDI CRISTINA, AntoniettaDUSONCHET, LuisaMELI, Maria + | 01 - Contributo in rivista::1.01 Articolo in rivista | SIMONI D; GRISOLIA G; GIANNINI G; ROBERTI M; RONDANIN R; PICCAGLI L; BARUCHELLO R; ROSSI M; ROMAGNOLI R; INVIDIATA FP; GRIMAUDO S; JUNG MK; HAMEL E; GEBBIA N; CROSTA L; ABBADESSA V; DI CRISTINA A; DUSONCHET L; MELI M; TOLOMEO M | |
| 1-gen-2009 | Histone deacetylase (HDAC) inhibition modulates intracellular deoxynucleotides (dNTP) pools and potentiates the antitumor effects of the ribonucleotide reductase (RR) inhibitor 3’-Methyl-adenosine (3’-Me-Ado) in promyelocitic leukaemia cell lines. | MELI, MariaDUSONCHET, Luisa + | 10 - Proceedings::Proceedings | Meli, M; Tolomeo, M; Grifantini, M; Mai, A; Cappellacci, L; Franchetti, P; Saiko, P; Dusonchet, L | |
| 1-gen-2008 | Histone deacetylase (HDAC) inhibitors potentiate the antiproliferative and apoptotic effects induced by the novel ribonucleotide reductase (RR) inhibitor 3'-metil-adenosine (3'-Me-Ado) in promyelocitic leukemia cell lines | MELI, MariaDUSONCHET, Luisa + | 10 - Proceedings::Proceedings | MELI M; TOLOMEO M; GRIFANTINI M; MAI A; CAPPELLACCI L; FRANCHETTI P; ROTILI D; VALENTE S; DUSONCHET L |